KRSA
Korsana Biosciences Inc.
KRSA | NASDAQ
$31.20
+$1.06 (+3.52%)
Nov 2, 2026, 10:32 AM ET · Market open
Market Data
Market Cap $146.06M
Enterprise Value $139.7M
Beta 1.73
Average Volume 48.45K
Shares Outstanding (Diluted) 607.29K
Shares Change YoY 38.42%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US23255M3034
Price Performance
Price Change 1M 2.3%
Price Change 3M 27.7%
Price Change 6M 36.7%
Price Change YTD 251.0%
Price Change 1Y 139.6%
Price Change 3Y 90.5%
Price Change 5Y -91.8%
1M CAGR (ann.) -13.9%
1Y CAGR (ann.) 118.6%
5Y CAGR (ann.) -39.9%
All-Time CAGR -41.3%
Valuation
PE Ratio -2.50
Forward PE N/A
PEG Ratio 0.03
Forward PEG 0.04
PS Ratio 74.26
Forward PS 240.70
PB Ratio 27.74
P/FCF Ratio -31.70
P/Adj. FCF Ratio -30.16
P/OCF Ratio -4.11
EV/Sales 73.53
EV/EBIT -20.83
EV/EBITDA -20.83
EV/FCF -31.39
Earnings Yield -40.0%
FCF Yield -3.1%
Adj. FCF Yield -3.3%
Financial Health
Net Cash $1.39M
Total Debt $0
Cash & Short-Term Investments $1.39M
Total Assets $6.93M
Current Ratio 0.82
Quick Ratio 0.82
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score -12.79
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 61.6%
Operating Profit Margin -359.2%
EBITDA Margin -353.0%
Net Profit Margin -353.0%
FCF Margin -234.3%
Adj. FCF Margin -246.2%
SBC / Revenue 11.9%
SBC Impact (per share) -5.1%
Returns
Return on Assets -96.8%
Return on Equity -88.0%
Return on Invested Capital -134.2%
Return on Capital Employed -134.2%
Return on Tangible Assets -96.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 70.0%
Revenue CAGR 5Y -12.0%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 68.0%
EPS CAGR 5Y 62.9%
EPS CAGR 10Y N/A
FCF CAGR 3Y 56.1%
FCF CAGR 5Y 55.5%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y 24.5%
Revenue Growth Next 3Y -55.7%
Earnings Date Nov 11, 2026
EPS Estimate (next Q) -$0.85
EPS Growth Est (next Q) 182.3%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $53.00
Price Target Upside 75.8%
Cash Flow
Operating Cash Flow $-4.45M
Free Cash Flow $-4.45M
Adj. Free Cash Flow $-4.68M
FCF Per Share -$7.33
OCF Per Share -$7.33
OCF/S Ratio -234.3%
Income Statement
Revenue $1.9M
Gross Profit $1.17M
Operating Income $-6.82M
EBITDA $-6.71M
Net Income $-6.71M
EPS (Diluted) -$12.04
Revenue / Employee $100K
Profit / Employee $-353K
Employees 19
Add to Watchlist
Select watchlists to add or remove KRSA